These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 7654127
1. Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Jeste DV, Caligiuri MP, Paulsen JS, Heaton RK, Lacro JP, Harris MJ, Bailey A, Fell RL, McAdams LA. Arch Gen Psychiatry; 1995 Sep; 52(9):756-65. PubMed ID: 7654127 [Abstract] [Full Text] [Related]
3. Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ, Caligiuri MP. Am J Psychiatry; 1999 Feb; 156(2):309-11. PubMed ID: 9989570 [Abstract] [Full Text] [Related]
4. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Glazer WM, Morgenstern H, Doucette JT. J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030 [Abstract] [Full Text] [Related]
5. Changing epidemiology of tardive dyskinesia: an overview. Jeste DV, Wyatt RJ. Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344 [Abstract] [Full Text] [Related]
6. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. Jeste DV, Lacro JP, Bailey A, Rockwell E, Harris MJ, Caligiuri MP. J Am Geriatr Soc; 1999 Jun; 47(6):716-9. PubMed ID: 10366172 [Abstract] [Full Text] [Related]
8. High incidence of tardive dyskinesia in older outpatients on low doses of neuroleptics. Harris MJ, Panton D, Caligiuri MP, Krull AJ, Tran-Johnson TK, Jeste DV. Psychopharmacol Bull; 1992 Jun; 28(1):87-92. PubMed ID: 1609047 [Abstract] [Full Text] [Related]
9. Duration of neuroleptic treatment and prevalence of tardive dyskinesia in late life. Sweet RA, Mulsant BH, Gupta B, Rifai AH, Pasternak RE, McEachran A, Zubenko GS. Arch Gen Psychiatry; 1995 Jun; 52(6):478-86. PubMed ID: 7771918 [Abstract] [Full Text] [Related]
11. Incidence and risk factors for severe tardive dyskinesia in older patients. Caligiuri MP, Lacro JP, Rockwell E, McAdams LA, Jeste DV. Br J Psychiatry; 1997 Aug; 171():148-53. PubMed ID: 9337951 [Abstract] [Full Text] [Related]
12. Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study. Paulsen JS, Caligiuri MP, Palmer B, McAdams LA, Jeste DV. Psychopharmacology (Berl); 1996 Feb; 123(4):307-14. PubMed ID: 8867868 [Abstract] [Full Text] [Related]
13. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables. Mukherjee S, Rosen AM, Cardenas C, Varia V, Olarte S. Arch Gen Psychiatry; 1982 Apr; 39(4):466-9. PubMed ID: 6121547 [Abstract] [Full Text] [Related]
14. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM. J Clin Psychiatry; 2010 Apr; 71(4):463-74. PubMed ID: 20156410 [Abstract] [Full Text] [Related]